Zero Candida Receives South African Patent for its ZC- 01 device

VANCOUVER, BC, Dec. 9, 2024 /PRNewswire/ — Zero Candida (the “Company” or “ZC”) (TSXV: ZCT), an Israeli FemTech medical device start-up, is pleased to announce the Company has received a final patent from South Africa PCT patent PCT-IL 2023050243 in South Africa. In addition, the company is actively pursuing a global patent portfolio with applications filed worldwide including in the United States, Brazil, and Europe.

Are you an angel?

Public Announcements

Zero Candida Receives South African Patent for its ZC- 01 device

VANCOUVER, BC, Dec. 9, 2024 /PRNewswire/ — Zero Candida (the “Company” or “ZC”) (TSXV: ZCT), an Israeli FemTech medical device start-up, is pleased to announce…

Zero Candida Announces Full Transaction and Being Trading November 25th on the TSX Venture Exchange (Canada)

VANCOUVER, BC, Nov. 25, 2024 /PRNewswire/ — Zero Candida (the “Company” or “ZCT”), (TSXV: ZCT) an Israeli FemTech medical device start-up, is pleased to announce…

Zero Candida Announces TSX Venture Exchange Listing Date

Zero Candida (formerly 1319743 B.C. Ltd.), has recently completed its business acquisition of Zero Candida Ltd., an Israeli private company (“ZC” and “Acquisition” respectively). In…